NDC 14783-028

LBel Paris Renovance Jour

Octinoxate, Octocrylene, And Oxybenzone

LBel Paris Renovance Jour is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Ventura International Ltd. The primary component is Octinoxate; Octocrylene; Oxybenzone.

Product ID14783-028_0c3c71b9-8f8d-4de9-8fe4-04a2cb405093
NDC14783-028
Product TypeHuman Otc Drug
Proprietary NameLBel Paris Renovance Jour
Generic NameOctinoxate, Octocrylene, And Oxybenzone
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2010-08-15
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart352
Labeler NameVentura International LTD
Substance NameOCTINOXATE; OCTOCRYLENE; OXYBENZONE
Active Ingredient Strength0 g/5g; g/5g; g/5g
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 14783-028-51

1 JAR in 1 BOX (14783-028-51) > 5 g in 1 JAR (14783-028-52)
Marketing Start Date2010-08-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 14783-028-52 [14783002852]

LBel Paris Renovance Jour CREAM
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-08-15

NDC 14783-028-51 [14783002851]

LBel Paris Renovance Jour CREAM
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-08-15
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
OCTINOXATE.375 g/5g

OpenFDA Data

SPL SET ID:c79594c9-3534-45ff-a992-9b08b6934241
Manufacturer
UNII

NDC Crossover Matching brand name "LBel Paris Renovance Jour" or generic name "Octinoxate, Octocrylene, And Oxybenzone"

NDCBrand NameGeneric Name
14783-018LBel ParisOctinoxate, Octocrylene, and Oxybenzone
14783-028LBel ParisOctinoxate, Octocrylene, and Oxybenzone
14783-038LBel ParisOctinoxate, Octocrylene, and Oxybenzone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.